Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Childhood tumors

R J Packer1

  • 1Department of Neurology, Children's National Medical Center, Washington, DC 20010, USA.

Current Opinion in Neurology
|January 13, 1998
PubMed
Summary
This summary is machine-generated.

Advances in treating childhood brain tumors are slow but steady. Chemotherapy improves survival for medulloblastoma and is effective for low-grade glial tumors, though results vary for other malignant types.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MRI Features of Histologically Diagnosed Supratentorial Primitive Neuroectodermal Tumors and Pineoblastomas in Correlation with Molecular Diagnoses and Outcomes: A Report from the Children's Oncology Group ACNS0332 Trial.

AJNR. American journal of neuroradiology·2019
Same author

Treatment of pediatric cerebral radiation necrosis: a systematic review.

Journal of neuro-oncology·2016
Same author

Remarkable oxide ion conductivity observed at low temperatures in a complex superstructured oxide.

Advanced materials (Deerfield Beach, Fla.)·2010
Same author

CNS germ cell tumor (CNSGCT) of childhood: presentation and delayed diagnosis.

Neurology·2007
Same author

NF1 plexiform neurofibroma growth rate by volumetric MRI: relationship to age and body weight.

Neurology·2007
Same author

Treatment strategies for medulloblastoma and primitive neuroectodermal tumors.

Neurosurgical focus·2006
Same journal

Movement disorders and Parkinson's disease: collaborative and interdisciplinary research to advance understanding of neural circuit dysfunction, pathophysiology, and care: new horizons in technology, neuroimaging, neurophysiology, and genetics toward personalized medicine.

Current opinion in neurology·2026
Same journal

Editorial introduction.

Current opinion in neurology·2026
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
See all related articles

Area of Science:

  • Pediatric Oncology
  • Neuro-oncology
  • Cancer Therapeutics

Background:

  • Primary childhood brain tumors represent a significant challenge in pediatric oncology.
  • Treatment advances for these complex diseases have historically been slow.
  • Understanding the nuances of different tumor types is crucial for effective management.

Purpose of the Study:

  • To review the current state of treatment for primary childhood brain tumors.
  • To highlight the impact of chemotherapy on survival rates.
  • To identify areas where therapeutic progress has been made and where challenges remain.

Main Methods:

  • Literature review of recent studies on childhood brain tumor treatments.
  • Analysis of chemotherapy efficacy in various pediatric brain tumor subtypes.

Related Experiment Videos

  • Evaluation of survival data in response to different therapeutic strategies.
  • Main Results:

    • Chemotherapy has demonstrably improved survival outcomes for pediatric medulloblastoma.
    • High-dose chemotherapy shows variable efficacy across different malignant childhood tumors.
    • Chemotherapy has proven effective in treating low-grade glial tumors in children.

    Conclusions:

    • While progress is gradual, chemotherapy offers a viable treatment option for specific pediatric brain tumors.
    • Further research is needed to optimize chemotherapy regimens and improve outcomes for all childhood brain tumor types.
    • Targeted therapeutic advancements are essential for addressing slower progress in other tumor categories.